Comparative Evaluation of Salivary and Serum High-Sensitive C-Reactive Protein in Acute Myocardial Infarction

AIM: The aim of this study is to comparatively evaluate the serum and salivary high-sensitive C-reactive protein (hs-CRP) in patients with acute myocardial infarction (MI). SUBJECTS AND METHODS: The study group consisted of 60 patients of whom 30 were MI patients and 30 were controls. Serum hs-CRP w...

Descripción completa

Detalles Bibliográficos
Autores principales: SaranyaDevi, K. Sakthi, Rekha, B. Sasi, Thiyagarajan, J. Vijay, Dhivya, R., Mihiran, Suriyahanth, Santhosh, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469396/
https://www.ncbi.nlm.nih.gov/pubmed/36110764
http://dx.doi.org/10.4103/jpbs.jpbs_845_21
Descripción
Sumario:AIM: The aim of this study is to comparatively evaluate the serum and salivary high-sensitive C-reactive protein (hs-CRP) in patients with acute myocardial infarction (MI). SUBJECTS AND METHODS: The study group consisted of 60 patients of whom 30 were MI patients and 30 were controls. Serum hs-CRP was assessed using particle-enhanced immunoturbidimetric assay. Saliva hs-CRP is determined using a microplate reader cum UV photospectrometer from BMG. RESULTS: In this study, levels of both serum and salivary hs-CRP in control and MI patients showed a positive correlation. Saliva can be used as an alternative biofluid to determine hs-CRP in MI patients. CONCLUSION: Saliva can be used as a alternative biofluid to determine the risk as well as to determine prognosis in acute myocardial infarction.

Ejemplares similares